Nuvig Therapeutics logo

Nuvig Therapeutics Funding & Investors

Redwood City, CA

Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmune diseases.

nuvigtherapeutics.com

Total Amount Raised: $208,000,000

Nuvig Therapeutics Funding Rounds

  • Series B

    $161,000,000

    Series B Investors

    Blue Owl
    Norwest Venture Partners
    Genzyme
    Cowen
    B Capital
    Leaps by Bayer
    Abrdn
    Global BioAccess Fund
    Alexandria Venture Investments
    Lotte
    Wu Capital
    Novo Holdings
    Digitalis Ventures
    Bristol-Myers Squibb Company
    Mission BioCapital
    PLATANUS
  • Series A

    $47,000,000

    Series A Investors

    Novo Holdings
    Digitalis Ventures
    Mission BioCapital
    Bristol-Myers Squibb Company
Funding info provided by Diffbot.